Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.

Abstract

Alzheimer's disease (AD) is a progressive brain disorder which occurs due to lower levels of acetylcholine (ACh) neurotransmitters, and results in a gradual decline in memory and other cognitive processes. Acetycholinesterase (AChE) and butyrylcholinesterase (BChE) are considered to be primary regulators of the ACh levels in the brain. Evidence shows that… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.